TB/HIV 2019 symposium

A new era in TB prevention: Implications for people living with HIV

The International AIDS Society HIV Co-Infections and Co-Morbidities initiative convened the TB/HIV 2019 Symposium just prior to IAS 2019 in Mexico, as an event entirely devoted to research and implementation focused on TB prevention. The event was co-hosted by the International AIDS Society (IAS) in collaboration with the Stop TB Partnership and the United States Agency for International Development (USAID).

This symposium represented a unique opportunity to bring together a diversity of scientific, programmatic and community interests from of both the HIV and TB fields to share current knowledge on science of latent TB infection, as well as present and future opportunities and challenges in HIV-associated TB prevention. Sessions explored the latent TB infection, from the biology and immunology perspective, current and future treatment options and the policy and implementation perspectives to decrease the burden of TB in HIV programs, including programmatic approaches through primary health care and differentiated service delivery as crucial opportunities to reach global TB an HIV goals worldwide. Additional focus was given to the current and future developments of TB vaccines and the relevance and implications for high burden HIV settings.

The programme included a mixture of formats, such as focused thematic keynotes, a panel discussion, as well as an abstract driven poster exhibition, in addition to the views from the civil society. A final Call to action for a coordinated HIV and TB response to reach 6 million people living with HIV with tuberculosis preventive treatment aimed to galvanize global and national efforts to increase coverage and reach the new TB prevention goals globally.

Find the presentations, multimedia and more below.

Meeting material

  • Presentations
  • Multimedia
  • Programme
  • Commitee

Session 1

People at the centre: Living with HIV and TB
Maurine Murenga, Kenya

Presentation

Keynote speaker: Building a tuberculosis-free world: The Lancet Commission on tuberculosis
Eric Goosby, University of California, USA

Presentation

The UN HLM TB prevention targets: Finding synergies between the HIV and TB programmes
Suvanand Sahu, Stop TB Partnership, Switzerland

Presentation

Session 2

Understanding TB latency today and its opportunities for HIV and TB programmes
Rogelio Hernandez Pando, Instituto Nacional Salvador, Zubirán

Presentation

Current options for treatment for TB latent infection
Richard Chaisson, Johns Hopkins University, USA

Presentation

Long-acting formulations for the treatment of latent TB infection: opportunities and challenges
Susan Swindells, University of Nebraska, USA

Presentation

Current strategies and pipeline for novel TB vaccines
Willem Hanekom, Bill & Melinda Gates Foundation, USA

Presentation

Session 3

TB prevention in HIV-associated TB: Opportunities and challenges
Andrea Howard, Columbia University, USA

Presentation

TB prevention in pregnant women and children
Jyoti Mathad, Weill Cornell Medical College, USA

Presentation

Prevention of DR-TB
Gavin Churchyard, The Aurum Institute, South Africa

Presentation

Operationalizing tools to scale up TB preventive treatment
Sean Cavanaugh, CDC, USA

Presentation

Scaling TB preventive treatment: The experience of South Africa
Hala Almossawi, USAID, USA

Presentation

Session 4

Maximizing engagement in care and adherence to TB preventive treatment
Lucy Connell, USAID, South Africa

Presentation

Use of differentiated service delivery approaches for TB prevention and care
Peter Preko, ICAP, eSwatini

Presentation

The right to TB preventive treatment: Considerations for access and equity for key populations
Harry Hausler, TB HIV Care, South Africa

Presentation

Perspectives from the community: Demand creation and promotion of TB preventive treatment
Esnath Manhiri, Zimbabwe National Network of People Living with HIV

Presentation

Lessons learnt from scaling up TB prevention programmes from a national HIV programme
Gabriella Tabares, TB Programme Director/Deputy HIV Programme Director, Brazil

Presentation

Photo galleries

Videos

Session 1

  • People at the center: living with HIV and TB
    Maurine Murenga (Kenya)

  • Keynote speaker: Building a tuberculosis-free world (The Lancet Commission on tuberculosis)
    Eric Goosby (University of California, USA)

  • The UN HLM TB prevention targets: Finding synergies between the HIV and TB programmes
    Suvanand Sahu (Stop TB Partnership, Switzerland)

  • Remarks from the WHO perspective
    Meg Doherty (World Health Organization, Switzerland)

Session 2

  • Long-acting formulations for the treatment of latent TB infection: opportunities and challenges
    Susan Swindells (University of Nebraska, USA)

  • Current options for treatment for TB latent infection
    Richard Chaisson (Johns Hopkins University, USA)

  • Understanding TB latency today and its opportunities for HIV and TB programmes
    Rogelio Hernandez Pando (Instituto Nacional Salvador Zubirán, Mexico)

  • Current strategies and pipeline for novel TB vaccines
    Willem Hanekom (Bill & Melinda Gates Foundation, USA)

Session 3

  • TB prevention in HIV-associated TB: opportunities and challenges
    Andrea Howard (Columbia University, USA)

  • TB prevention in pregnant women and children
    Jyoti Mathad ( Weill Cornell Medical College, USA)

  • Prevention of DR-TB
    Gavin Churchyard (Aurum Institute, South Africa)

  • Operationalizing tools to scale up TB preventive treatment
    Sean Cavanaugh (Office of the Global AIDS Coordinator, USA)

  • Scaling TB preventive treatment: The experience of South Africa
    Hala Almossawi (USAID, USA)

Session 4

  • Maximizing engagement in care and adherence to TB preventive treatment
    Lucy Connell (USAID, South Africa)

  • Use of Differentiated Service Delivery approaches for TB prevention and Care
    Peter Preko (ICAP, eSwatini)

  • Perspectives from a community based organization in the scale up integrated TB/HIV services
    Harry Haussler (TBHIV Care, South Africa)

  • Perspectives from the community: demand creation and promotion of preventative treatment
    Esnath Manhiri (Zimbabwe National Network of People Living with HIV, Zimbabwe)

  • Lessons learnt from scaling up TB prevention programs from a National HIV programme
    Gabriella Tabares (TB Programme Director/ Deputy HIV Programme Director, Brazil)

Programme


Programme

Co-chairs
Dr Alfredo Ponce de León, National Institute Salvador Zubirán, Mexico
Dr Beatriz Grinsztejn, Instituto National de Infectologia Evando Chagas-Fiocruz and IAS Governing Council member , Brazil

Organizing committee members
Sevim Ahmedov, United States Agency for International Development (USAID), United States
Suvanand Sahu, Stop TB Partnership, Switzerland
Vindi Singh, HIV Department, World Health Organisation, Switzerland
Adeeba Kamarulzaman, University of Malaysia, Malaysia
Eduardo Gotuzzo, Instituto de Medicina Tropical, Peru
Gavin Churchyard, The Aurum Institute, South Africa
Susan Swindells, University of Nebraska Medical Centre, United States
Grania Brigden, International Union Against Tuberculosis and Lung Disease , Switzerland
Wim Vandevelde, GNP+, South Africa
Lucia Gonzalez Fernandez, International AIDS Society, Switzerland

Partners

       

Call to action for a coordinated HIV and TB response to reach 6 million people living with HIV with tuberculosis preventive treatment

Find out more